Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.

Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.
Related ArticlesAdvances in the development of imaging probes and aggregation inhibitors for alpha-synuclein. Acta Pharmacol Sin. 2019 Oct 04;: Authors: Xu MM, Ryan P, Rudrawar S, Quinn RJ, Zhang HY, Mellick GD Abstract Abnormal protein aggregation has been linked to many neurodegenerative diseases, including Parkinson's disease (PD). The main pathological hallmark of PD is the formation of Lewy bodies (LBs) ... read more
Source: PubMedPublished on 2019-10-06